Benedict Financial Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.31M Sell
8,562
-143
-2% -$53K 0.64% 53
2026
Q1
$2.55M Sell
8,705
-189
-2% -$62.1K 0.53% 67
2025
Q4
$3.12M Buy
8,894
+145
+2% +$49K 0.66% 50
2025
Q3
$2.83M Buy
8,749
+384
+5% +$119K 0.61% 58
2025
Q2
$3.25M Buy
8,365
+86
+1% +$34.6K 0.74% 47
2025
Q1
$3.6M Buy
8,279
+63
+0.8% +$25.3K 0.83% 41
2024
Q4
$3.03M Sell
8,216
-34
-0.4% -$14.2K 0.74% 54
2024
Q3
$4.29M Sell
8,250
-32
-0.4% -$17.1K 1.01% 33
2024
Q2
$4.49M Sell
8,282
-137
-2% -$72.4K 1.14% 29
2024
Q1
$4.37M Buy
8,419
+50
+0.6% +$24.9K 1.11% 30
2023
Q4
$3.95M Sell
8,369
-21
-0.3% -$9.71K 1.08% 30
2023
Q3
$3.65M Sell
8,390
-75
-0.9% -$34K 1.06% 35
2023
Q2
$3.76M Sell
8,465
-41
-0.5% -$18.9K 1.03% 34
2023
Q1
$3.91M Sell
8,506
-119
-1% -$56.6K 1.1% 33
2022
Q4
$4.42M Sell
8,625
-144
-2% -$73.1K 1.31% 26
2022
Q3
$3.98M Sell
8,769
-57
-0.6% -$27.3K 1.27% 28
2022
Q2
$4.26M Sell
8,826
-95
-1% -$47K 1.26% 29
2022
Q1
$4.38M Sell
8,921
-47
-0.5% -$21.5K 1.17% 33
2021
Q4
$4.16M Sell
8,968
-181
-2% -$76.1K 1.08% 32
2021
Q3
$3.41M Sell
9,149
-32
-0.3% -$12.2K 0.95% 43
2021
Q2
$3.5M Sell
9,181
-50
-0.5% -$19.1K 0.97% 41
2021
Q1
$3.31M Sell
9,231
-175
-2% -$56.3K 0.96% 41
2020
Q4
$3.02M Sell
9,406
-28
-0.3% -$8.59K 1.09% 35
2020
Q3
$2.53M Sell
9,434
-18
-0.2% -$4.84K 0.98% 38
2020
Q2
$2.49M Sell
9,452
-30
-0.3% -$8K 1.03% 37
2020
Q1
$2.15M Sell
9,482
-91
-1% -$24.8K 1.01% 38
2019
Q4
$2.89M Sell
9,573
-160
-2% -$44K 1.13% 35
2019
Q3
$2.34M Sell
9,733
-145
-1% -$39.7K 0.96% 44
2019
Q2
$2.79M Sell
9,878
-99
-1% -$27K 1.16% 32
2019
Q1
$2.86M Sell
9,977
-436
-4% -$126K 1.24% 29
2018
Q4
$2.73M Sell
10,413
-562
-5% -$155K 1.35% 27
2018
Q3
$3.01M Sell
10,975
-438
-4% -$114K 1.35% 27
2018
Q2
$2.72M Sell
11,413
-120
-1% -$27.8K 1.34% 28
2018
Q1
$2.53M Sell
11,533
-709
-6% -$167K 1.28% 29
2017
Q4
$2.75M Sell
12,242
-589
-5% -$125K 1.33% 29
2017
Q3
$2.44M Sell
12,831
-528
-4% -$100K 1.25% 33
2017
Q2
$2.55M Sell
13,359
-620
-4% -$111K 1.33% 32
2017
Q1
$2.31M Sell
13,979
-487
-3% -$77.5K 1.26% 34
2016
Q4
$2.08M Sell
14,466
-110
-0.8% -$14.7K 1.2% 35
2016
Q3
$1.79M Buy
14,576
+376
+3% +$48.5K 1.04% 38
2016
Q2
$1.87M Buy
14,200
+121
+0.9% +$16.6K 1.1% 39
2016
Q1
$1.96M Buy
14,079
+416
+3% +$55.6K 1.19% 35
2015
Q4
$1.91M Buy
13,663
+649
+5% +$89.4K 1.21% 35
2015
Q3
$1.82M Buy
13,014
+1,005
+8% +$151K 1.26% 33
2015
Q2
$1.86M Buy
12,009
+238
+2% +$38K 1.21% 33
2015
Q1
$1.81M Sell
11,771
-22
-0.2% -$3.13K 1.16% 33
2014
Q4
$1.6M Buy
+11,793
New +$1.46M 1.05% 40

Other funds holding ELV

Benedict Financial Advisors's ELV Position: Q2 2026 in Review

Benedict Financial Advisors reduced its Elevance Health (ELV) stake by 1.6% in Q2 2026, selling an estimated $53K and leaving 8,562 shares worth $3.31M. The position accounts for 0.64% of the portfolio, ranked #53.

Benedict Financial Advisors first reported a position in ELV in Q4 2014 and has held it in 47 quarters since. The position peaked at $4.49M in Q2 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Benedict Financial Advisors held 8,562 shares of Elevance Health worth $3.31M as of Q2 2026.
  • Benedict Financial Advisors sold 143 Elevance Health shares in Q2 2026, an estimated $53K.
  • Elevance Health made up 0.64% of Benedict Financial Advisors's portfolio in Q2 2026, its #53 holding.
  • Benedict Financial Advisors first reported a position in Elevance Health in Q4 2014 and has held it in 47 quarters since.
  • Benedict Financial Advisors's Elevance Health position peaked at $4.49M in Q2 2024.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Benedict Financial Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.